Coloplast to Acquire Atos Medical from PAI Partners for c. €2.2 billion
November 8, 2021
Coloplast has agreed to acquire Atos Medical from private equity firm PAI Partners for an enterprise value of approximately €2.2 billion. Atos Medical, headquartered in Malmö, Sweden, is a global leader in laryngectomy and tracheostomy products with ~1,150 employees and a direct presence in 30 countries; the deal is subject to customary regulatory approvals and was anticipated to close in Q1 2022.
- Buyers
- Coloplast
- Targets
- Atos Medical
- Sellers
- PAI Partners
- Industry
- Medical Devices
- Location
- Skåne County, Sweden
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Atos Acquires Processia
April 20, 2021
IT Services
Atos has agreed to acquire Processia, a Canada-headquartered Product Lifecycle Management (PLM) system integrator and Dassault Systèmes Global Service Partner. The acquisition adds ~250 professionals to Atos, strengthening its PLM and engineering solutions capabilities and expanding its footprint in North America and Europe to support manufacturers’ Industry 4.0 transformations.
-
ATHOS Consortium (led by ATHOS) Acquires Schülke from EQT Private Equity
August 7, 2023
Medical Devices
A consortium led by ATHOS, a Munich-based single family office, together with co-investors including Bitburger Holding, agreed to acquire Schülke from EQT Private Equity. Schülke, headquartered in Norderstedt, Germany, is a leading provider of infection prevention and treatment solutions for healthcare and life sciences, employing ~1,200 people and operating in more than 80 countries; the deal is expected to close in Q4 2023 and is subject to regulatory approvals.
-
Atos Acquires Cloudreach
December 7, 2021
IT Services
Atos has agreed to acquire Cloudreach, a London-headquartered multi-cloud services provider, to strengthen its multi-cloud, application modernization and security capabilities. Cloudreach employs more than 600 people and generated roughly €100 million of revenue in 2021; the deal is subject to regulatory approvals and was expected to close in early Q1 2022.
-
Teleflex Acquires Palette Life Sciences
October 10, 2023
Medical Devices
Teleflex Incorporated completed its acquisition of Palette Life Sciences AB for $600 million in upfront cash plus up to $50 million in potential milestone payments. The deal adds Palette’s NASHA-based products — including the Barrigel rectal spacer, Deflux and Solesta — to Teleflex’s interventional urology portfolio; Palette’s standalone net revenue was expected to be about $56 million for 2023.
-
Atos Acquires Ipsotek
June 1, 2021
AI & Machine Learning
Atos has completed the acquisition of Ipsotek, a London-based provider of AI-enhanced video analytics, strengthening Atos' Edge AI and computer vision capabilities. Ipsotek brings its VISuite platform, approximately 50 professionals and more than 600 projects across 38 countries to Atos' portfolio to support public sector, retail, transportation, manufacturing and critical infrastructure use cases.
-
Olympus Partners Acquires PAI Pharma
February 24, 2025
Pharmaceuticals
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.